KRISTINA HAMMER: Open Payments
NPI 1639634199 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 9 payments from 8 companies in 2025. Trend: 2023 $69 · 2024 $112 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Solventum Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $14 |
Products named: FOTIVDA, DARZALEX, EMRELIS, ACTIV.A.C., FRUZAQLA, KEYTRUDA, Tecentriq, NERLYNX.
Industry payments across KY — which companies pay providers there.
